Organ on Chip Technology to Model Cancer Growth and Metastasis
Citations Over TimeTop 10% of 2022 papers
Abstract
Organ on chip (OOC) has emerged as a major technological breakthrough and distinct model system revolutionizing biomedical research and drug discovery by recapitulating the crucial structural and functional complexity of human organs in vitro. OOC are rapidly emerging as powerful tools for oncology research. Indeed, Cancer on chip (COC) can ideally reproduce certain key aspects of the tumor microenvironment (TME), such as biochemical gradients and niche factors, dynamic cell-cell and cell-matrix interactions, and complex tissue structures composed of tumor and stromal cells. Here, we review the state of the art in COC models with a focus on the microphysiological systems that host multicellular 3D tissue engineering models and can help elucidate the complex biology of TME and cancer growth and progression. Finally, some examples of microengineered tumor models integrated with multi-organ microdevices to study disease progression in different tissues will be presented.
Related Papers
- → NewsCAP: American Cancer Society predicts new cancer cases and cancer deaths(2018)1 cited
- Sapporo cancer seminar: membrane-associated alterations in cancer--biochemical strategies against cancer.(1983)
- Cancer stem-cells in oral cancer and pre-cancer(2015)
- The nutrition of the cancer patient. Sponsored by the National Cancer Institute's Diet, Nutrition, and Cancer Program and the Division of Cancer Treatment. National Institutes of Health, January 10-11, 1981.(1981)